| Year | Firm | Client | Amount | Doc |
|---|---|---|---|---|
| 2026 3rd Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $110,000 | |
| 2026 2nd Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $140,000 | |
| 2026 1st Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $220,000 | |
| 2025 4th Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $150,000 | |
| 2025 3rd Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $210,000 | |
| 2025 2nd Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $270,000 | |
| 2024 4th Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $120,000 | |
| 2024 3rd Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $190,000 | |
| 2024 2nd Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $120,000 | |
| 2024 1st Quarter - Report |
NOVOZYMES NORTH AMERICA, INC. | NOVOZYMES NORTH AMERICA, INC. | $110,000 |